Decides on director candidates and discloses the names, appointments, and resignations of director candidates. Background information on the new candidate is provided, with formal decisions expected at the 44th ordinary general meeting of shareholders to be held on August 28, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3349","jir_company_name":"Cosmos Pharmaceutical","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3349-20260803-01.pdf","jir_short_summary":"Decides on director candidates and discloses the names, appointments, and resignations of director candidates. Background information on the new candidate is provided, with formal decisions expected at the 44th ordinary general meeting of shareholders to be held on August 28, 2026.","jir_summary":"### Decision on director candidates and the upcoming approval process\nAt today's board meeting, director candidates including President and Representative Director Hideaki Yokoyama were decided, and after the candidates are approved at the 44th Ordinary General Meeting of Shareholders scheduled for August 28, 2026, they will be formally decided at the board meeting scheduled for the same day. The new candidate is Motoki Takemori, currently Head of Corporate Planning. Shiro Uno is Head of Finance and Accounting. The resignations include Ta Shibata, resigning from the Legal Affairs Department.\n\n### Background of the new candidate and future personnel trends\nMotoki Takemori has been with the company since 1994, progressing through roles including Sales Department Product Manager, Product Director, Director of Product, Director of Sales Planning, Store Development Manager, and Head of Finance and Accounting, and is expected to continue in his current role as Head of Corporate Planning as the new director candidate.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#CosmosPharmaceutical, #ExecutiveChanges, #IR","jir_key_figures":"New director candidate: Motoki Takemori\nResigning director: Ta Shibata\nBackground of the new candidate: since 1994, positions held (current: Head of Corporate Planning)","jir_meta_title":"Cosmos Pharmaceutical: Notice of Director Candidate Decision | August 2026","jir_meta_description":"Cosmos Pharmaceutical has decided on director candidates. Disclosure of new appointments, resignations, and backgrounds. Formal decision at the 44th Ordinary General Meeting of Shareholders planned.","jir_og_title":"Cosmos Pharmaceutical: Notice of Director Candidate Decision | August 2026","jir_og_description":"Announcement of director candidate decisions and resignations, with background of the new candidate disclosed. Formal decision planned at the Ordinary General Meeting.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7750,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-93427","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n